Biofourmis, a Singapore-based start-up that uses digital therapeutics for the treatment of chronic conditions, announced on Wednesday that it has closed US$35 million in a series B round of financing from investors including Chinese online healthcare platform Jianke. The investment took the total capital raised by Biofourmis to US$41.6 million, according to CrunchBase. Sequoia India, […]

Chinese Online Healthcare Platform Joins $35M Series B Round Of Singaporean Start-Up comes originally from China Money Network. All Rights Reserved.